Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

21 oct. 2020 08h00 HE | Source: ILiAD Biotechnologies

ILiAD Biotechnologies Announces Upcoming Presentation at the European Society for Paediatric Infectious Diseases 2020 Virtual Meeting

WESTON, Fla., Oct. 21, 2020 (GLOBE NEWSWIRE) -- ILiAD Biotechnologies, LLC (ILiAD), a company utilizing proprietary B-Tech technology to develop next generation infectious disease vaccines, today...
29 sept. 2020 17h00 HE | Source: ILiAD Biotechnologies

ILiAD Biotechnologies Reports Positive Topline Results from Phase 2b Trial for Pertussis Vaccine Candidate BPZE1

-- Phase 2b study in healthy volunteers met primary endpoints of overall safety and induction of mucosal immunity ---- BPZE1 prevented colonization from re-vaccination/challenge in 90% of subjects...
24 sept. 2020 08h00 HE | Source: ILiAD Biotechnologies

ILiAD Biotechnologies Announces Presentation of Positive Phase 2b Data for Next Generation Pertussis Vaccine at World Vaccine Congress

WESTON, Fla., Sept. 24, 2020 (GLOBE NEWSWIRE) -- ILiAD Biotechnologies, LLC (ILiAD), a company utilizing proprietary B-Tech technology to develop next generation infectious disease vaccines, today...